VBI Vaccines to Present at Upcoming Investor Conferences

On June 17, 2020 VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, reported that members of the management team will participate in the following upcoming virtual investor conferences (Press release, VBI Vaccines, JUN 17, 2020, View Source [SID1234561181]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Raymond James’ Human Health Innovation Conference

– Presentation: Thursday, June 18, 2020 from 2:20-2:50 PM ET
– Webcast: View Source

BMO 2020 Prescription for Success Healthcare Conference

– Presentation: Tuesday, June 23, 2020 from 8:00-8:25 AM ET
– Webcast: View Source

Live webcasts of the presentations will also be available on the Investors page of VBI’s website at: View Source A replay of each webcast will be archived on the company’s website for 90 days following the presentation.